Company Description
ChemoCentryx is centering its research on chemokines. The drug developer is working on orally administered drugs that target the body's chemokine...
Key ChemoCentryx Financials
| Company Type | Private - NASDAQ (GM): CCXI Proposed Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2006 Sales (mil.) | $8.1 |
| 2006 Employees | 68 |
More ChemoCentryx Financials (4 pages)
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs....
Read more about ChemoCentryx's competition across multiple industries
Top ChemoCentryx Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
ChemoCentryx Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| President, CEO, and Director | Thomas J. Schall | Network | E-mail |
| Chief Business Officer and Treasurer | Markus J. Cappel | Network | E-mail |
| SVP, Finance, CFO, and Secretary | Susan M. Kanaya | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current ChemoCentryx News
- Cell migration assay [U.S. Patents] (15 Jul 2008 14:55:00 EDT)
- MONOCYCLIC AND BICYCLIC COMPOUNDS AND METHODS OF USE [European Patents] (24 Jun 2008 13:38:00 EDT)